key: cord-0825204-f7w7jnlg
authors: Ge, Jian‐wei; Deng, Shi‐ji; Xue, Zhi‐wei; Liu, Pin‐yi; Yu, Lin‐jie; Li, Jiang‐nan; Xia, Sheng‐nan; Gu, Yue; Bao, Xin‐yu; Lan, Zhen; Xu, Yun; Zhu, Xiao‐lei
title: Imperatorin inhibits mitogen‐activated protein kinase and nuclear factor kappa‐B signaling pathways and alleviates neuroinflammation in ischemic stroke
date: 2021-10-21
journal: CNS Neurosci Ther
DOI: 10.1111/cns.13748
sha: 918e85372b49b45d7ebad490e55dd35f708d64d1
doc_id: 825204
cord_uid: f7w7jnlg

AIMS: Microglia‐mediated neuroinflammation plays an important role in the pathological process of ischemic stroke, and the effect of imperatorin on post‐stroke neuroinflammation is not fully understood. METHODS: Primary microglia were treated with imperatorin for 2 h followed by LPS (100 ng/ml) for 24 h. The expression of inflammatory cytokines was detected by RT‐PCR, ELISA, and Western blot. The activation of MAPK and NF‐κB signaling pathways were analyzed by Western blot. The ischemic insult was determined using a transient middle cerebral artery occlusion (tMCAO) model in C57BL/6J mice. Behavior tests were used to assess the neurological deficits of MCAO mice. TTC staining was applied to measure infract volume. RESULTS: Imperatorin suppressed LPS‐induced activation of microglia and pro‐inflammatory cytokines release and attenuated ischemic injury in MCAO mice. The results of transcriptome sequencing and Western blot revealed that downregulation of MAPK and NF‐κB pathways might contribute to the protective effects of imperatorin. CONCLUSIONS: Imperatorin downregulated MAPK and NF‐κB signaling pathways and exerted anti‐inflammatory effects in ischemic stroke, which indicated that imperatorin might be a potential compound for the treatment of stroke.

Ischemic stroke is one of the most common causes of death and disability in the world. 1 However, the pathological mechanisms of ischemic brain injury are not fully understood. Increasing evidence indicates that neuroinflammation plays an important role in ischemic stroke. 2 Microglia, the resident macrophage in central nervous system (CNS), contributes to neuroinflammation after CNS injury. 3, 4 After being activated by various stimuli, microglia upregulates several proinflammatory mediators, including interleukin-1β (IL-1β), IL-6, tumor necrosis factorα (TNFα), nitric oxide (NO), and prostaglandin E2 (PGE2). 5 Interestingly, microglia activation exerts both protective and detrimental effects on ischemic stroke. 6 Microglia activation increases the release of several neurotoxic cytokines. 7 On the other hand, several studies have shown that microglia, the dynamic scavengers of cellular debris, contribute to the CNS homeostasis after ischemic stroke. 8 Thus, modulation of microglia function is an attractive therapeutic strategy for the treatment of ischemic stroke. Imperatorin (IMP), a linear furanocoumarin with molecular weight 270.28, is extracted from Angelica sinensis, Angelica dahurica.

(TCMSP) has shown that IMP has high oral bioavailability and great blood-brain barrier permeability. 9 IMP has shown potential biological activities in various disease models, such as anti-inflammatory, 10 anti-tumoral, 11 and anti-oxidative effects. 12 IMP activates Nrf2mediated anti-oxidative pathway to protect the RAW264.7 cells from inflammatory damage. 12 IMP ameliorates lipopolysaccharide (LPS)-induced memory deficit and attributes to the suppression of pro-inflammatory response. 13 In addition, IMP attenuates neuronal apoptosis and improves synaptic plasticity in a vascular dementia model. 14 In this study, we explored the effects of IMP on the activation of microglia and neuroinflammation in ischemic stroke, which might provide an alternative strategy for the treatment of ischemic stroke. 

Primary microglial cells were isolated from newborn C57BL/6J mice as previously described. 15 Cells were cultured in DMEM (Invitrogen) supplemented with 10% fetal bovine serum (FBS, Hyclone) in a 37°C humidified incubator for 10 days. Then, the separated microglial cells were seeded into 12-or 24-well plates for the subsequent experiments. The purity of the primary microglia was greater than 95%, which was examined by immunocytochemistry analysis using Iba-1 antibody (1:500; Wako, Japan).

All animal experiments were approved by the Animal Care and Use Committee at Nanjing University and designed according to the ARRIVE guidelines 2.0. 16 Male C57BL/6J mice (6-to 8-week-old) weighing 22 ± 2 g were used in this study. Mice were housed in a facility at a light cycle of 12-hr light/12-hr dark, with access to water and food ad libitum. Sixty mice were randomly divided into three groups, including sham-operate (SHAM) group, 5% dimethyl sulfoxide-treated MCAO (MCAO + DMSO) group, and IMP (5 mg/ kg)-treated MCAO (MCAO + IMP) group. Transient MCAO model was prepared as previously described. 17 Briefly, mice were anesthetized and maintained at 37±0.5°C on a heating pad. Under the dissecting microscope, the right common carotid artery and external carotid artery (ECA) were isolated. A piece of 6/0 monofilament nylon suture with a heat-rounded tip (Doccol corporation, MA, USA) was inserted into ECA and arranged to obstruct the origin of MCA.

Laser Doppler flowmetry (Perimed corporation, Stockholm, Sweden) was used to assess the cerebral blood flow. Mice were subjected to 60 min of occlusion, and the monofilament was withdrawn to allow blood reperfusion. All the mice were included in this study when the laser Doppler reading was below 30% of baseline and no hemorrhage occurred. Sham-operated animals underwent the same procedure without monofilament nylon suture inserting. The mice were treated with IMP (5 mg/kg) or vehicle intraperitoneally at 30 min, 24 h, and 48 h post-reperfusion.

Infarct volume was measured by 2, 3, 5-triphenyltetrazolium chloride (TTC, Sigma-Aldrich) staining as previously described. 18 Briefly, brains were cut into 1-mm-thick coronal slices and immersed in 2% TTC at 37°C. The photographs of the sections were taken with a digital camera and analyzed by ImageJ (ImageJ 1.5, NIH). The percentage of infarct was calculated as [(VC − VL)/VC] × 100, where VC was the volume of the infarcted tissue in the contralateral hemisphere and VL was the volume of the non-infarcted tissue in the ipsilateral hemisphere.

Modified neurological severity scores (mNSS) test was used for neurological function assessment at 24 and 72 h after perfusion as previously described. 19 The forelimb grip strength experiment was used to assess the motor function of the mice using a grip strength meter (GS3, Bioseb). During the experiment, mice were performed to hold a grid which was connected to an electronic digital force gauge. All mice were then gently pulled backward from the base of the tail and the maximum value was recorded. The data were averaged from five measurements of each mouse.

The rotarod experiment was performed to assess sensorimotor coordination and balance. 20 Briefly, mice were trained in the rotaroad (RWD Life Science) for 3 days before MCAO. During the test, the rotating rod was accelerated from 4 to 40 rpm in 5 min. All tests were performed twice with a 5-min period and a 10-min interval. The time when mice fell from the rotating rod was recorded. All neurobehavioral tests were performed by an experimenter who was blind to the experimental group.

Primary microglia were divided into 3 groups as follows: control group, LPS (100 ng/ml) treatment group, and IMP treatment group.

In the IMP-treated group, microglia were incubated with IMP (10, 30, or 50 μM) for 2 h, and then, LPS was added for another 24 h.

The concentration of nitrite in the supernatant produced by microglia was detected with a Griess reaction, which had high sensitivity and specificity for nitrite and nitrate by online reduction of nitrate to nitrite by cadmium and reduced copper, according to the manufacturer's instructions (Beyotime Biotech Nantong). Briefly, primary microglia were pretreated with IMP for 2 h and treated with LPS (100 ng/ml) for 24 h. Then, the culture media were collected, and the OD was measured at 540 nm.

The levels of cytokines including PGE2, IL-1β, IL-6, and TNFα in the supernatant were measured using the commercial ELISA kits as described in the manufacturer's protocol (Cusabio Biotech). The expression of the cytokines was obtained with a standard curve.

Primary microglia were digested, washed with phosphate-buffered saline (PBS) twice, and re-suspended in cold PBS at a density of 1 × 10 6 cells/ml. The microglia were incubated with CD86-APC or Arg1-APC in dark at 4°C for 30 min, and the expression of CD86 or Arg1 was detected by a FACS Calibur flow cytometer (BD Biosciences).

TRIzol reagent (Invitrogen Life Technologies, Carlsbad, CA, USA) was used to extract total RNA as described in our previous study. 21 Briefly, 1000 ng of total RNA was reverse transcribed in a 20 μl reaction at 37°C for 15 min followed by 85°C for 5 s using PrimeScript RT Master Mix (Vazyme Biotech Co.,ltd). Real-time PCR was performed on a Step One Plus PCR system (Applied Biosystems) using a SYBR Green Kit (Applied Biosystems).

The primers were as follows: 

The protein of brain tissues and microglia were extracted and quantified as previously described. 22, 23 Equal quantities of proteins were separated by 10% SDS-PAGE and then transferred to PVDF membranes. The membranes were blocked with 5% skim milk for 2 h at room temperature, and then, the membranes were incubated with primary antibodies against iNOS, IL-6, IL-1β, TNFα, ERK1/2, p-ERK1/2, JNK, p-JNK, p38, p-p38, NF-κBp65, p-NF-κBp65 (1:1000, Cell Signaling Technology), COX-2, or β-actin (1:5000, Bioworld Biotechnology) overnight at 4°C, and then, the membranes were incubated with HRP-conjugated secondary antibodies (Cell Signaling Technology) for 1 h at room temperature. The protein bands were visualized with the ECL Detection Kit (Bioworld Biotechnology). Images were acquired using the Gel-Pro system (Tanon Technologies), and the intensity of each band was analyzed using ImageJ software (ImageJ 1.5, NIH).

Mice brains were fixed with 4% paraformaldehyde and cut into 20μm sections using a Leica CM1900 cryostat after the gradient of dehydration. Microglia cells were fixed with 4% paraformaldehyde for 15 min. The brain sections and cell coverslips were washed 3 times with PBS, blocked in 2% fetal bovine serum, and incubated overnight at 4°C with following primary antibodies: Iba1 (1:500; Wako, Japan) or NF-κBp65 (1:200; Cell Signaling Technology). Then, these samples were incubated with indicated secondary antibodies for 2 h in dark at room temperature. DAPI (10 μg/ml) was added for 15 min to stain nuclei. The images were acquired with an Olympus BX51 (Japan) fluorescence microscope, and the relative area and integrated optical density (IOD) of microglia were analyzed using ImageJ software (ImageJ 1.5, NIH). 

All data were expressed as the mean ± standard deviation (SEM) of at least 3 independent experiments and analyzed by SPSS 20.0 (SPSS 20.0 software. USA). Shapiro-Wilk test was used to test the normality assumption of the data. Student's t test was used to compare differences between two groups if the data are normal distribution, while Mann-Whitney test was applied to compare the non-normally distributed variables. For more than two groups, statistical difference was analyzed by one-way analysis of variance (ANOVA) followed by Bonferroni's post hoc test or by the Kruskal-Wallis test followed by Dunn's multiple comparison test. p < 0.05 was considered to be statistically significant.

To evaluate the effects of IMP on neuroinflammation, the expression levels of inflammatory cytokines were examined in LPS-treated primary microglia. LPS treatment significantly increased the mRNA levels of iNOS, COX2, IL-1β, IL-6, and TNFα, while IMP could partially rescue these effects ( Figure 1A ). In addition, IMP inhibited the production of NO, PGE2, IL-1β, IL-6, and TNFα in the supernatant ( Figure 1B) and decreased the protein levels of iNOS, COX2, IL-1β, IL-6, and TNFα ( Figure 1C,D) in LPS-treated microglia. These results indicated that IMP suppressed LPS-induced inflammatory cytokines expression in primary microglia.

Since the expression of pro-inflammatory cytokines was decreased by IMP treatment, we examined the effects of IMP on morphological feature of microglia. The results showed LPS treatment increased the size of soma and enhanced intensity of Iba1 fluorescence, which was inhibited by IMP pretreatment (Figure 2A-C) . Comparing to control group, LPS treatment significantly increased the mRNA levels of CD86 and the amount of CD86 + microglia, and IMP pretreatment suppressed these effects ( Figure 2D-F) . Notably, the mRNA of Arg1, a marker of anti-inflammatory microglia, was also decreased following IMP pretreatment. However, the amount of LPS-induced Arg1 + microglia was not significantly changed following IMP pretreatment ( Figure 2G -I). These results indicated that IMP reversed LPS-induced microglia morphological changes and decreased the activation of pro-inflammatory microglia.

To further explore the mechanisms underlying the anti-inflammatory effects of IMP in microglia during ischemic stroke, transcriptomic sequencing was performed and the data showed that 198 genes were downregulated and 145 genes were upregulated in IMP group ( Figure 3A) . KEGG pathway analysis showed that several pathways including IL-17 signaling pathway, TNF signaling pathway, and mitogen-activated protein kinase (MAPK) signaling pathways were involved ( Figure 3B ,C). Since MAPK pathways played a critical role in the neuroinflammation, we tested whether IMP affected the MAPK pathways in LPS-induced microglia. The phosphorylation of JNK, ERK, and p38 was significantly increased by LPS treatment and decreased following IMP pretreatment ( Figure 3D,E) . NF-κB pathway plays a critical role in inflammation, and it has been reported that NF-κB pathway might act downstream of the MAPK signaling pathways. 24 Here, we found that IMP decreased the phosphorylation of NF-κBp65 in LPS-treated microglia ( Figure 3D ,E) and interfered the translocation of NF-κBp65 from cytoplasm to nucleus ( Figure 3F ).

Overall, our data revealed that IMP inhibited MAPK and NF-κB signaling pathways in LPS-induced microglia.

Next, we investigated whether IMP could reduce brain damage and improve neurological deficits in ischemic stroke. The results of TTC showed that the infarct volume of MCAO mice with IMP treatment was significantly decreased as compared with that of DMSO groups (28.32% ± 1.31% in IMP group vs. 34.82% ± 0.92% in DMSO group, Figure 4A Figure 4G) after MCAO. Collectively, these data indicated that IMP attenuated ischemic brain injury and neurological deficits in the ischemic stroke mice.

To determine the effects of IMP on neuroinflammation and microglia activation in MCAO mice, the mRNA levels of iNOS, IL-1β, IL-6, and TNFα were examined and it was shown that these pro-inflammatory cytokines were reduced in the ischemic hemisphere of IMP groups ( Figure 5A ). Meanwhile, IMP treatment reversed MCAO-induced increase of iNOS, IL-1β, IL-6, and TNFα protein levels ( Figure 5B,C) .

In addition, the activation of microglia was significantly suppressed by IMP administration as demonstrated by the immunofluorescent staining of Iba-1 ( Figure 5D ). Thus, our data indicated that IMP inhibited microglial activation and inflammatory response in the ischemic penumbra. The protein levels of iNOS, COX2, IL-1β, IL-6, and TNFα were analyzed via Western blot β-actin as an internal reference. The grey scale values of iNOS, COX2, IL-1β, IL-6, and TNFα in the blots were quantified by ImageJ software and normalized to β-actin and were represented as the fold change. The values were presented as the means ± SEM. The data shown here were representative of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 vs. control group; #p < 0.05, ##p < 0.01, ###p < 0.001vs. LPS-treated group

Microglia-mediated neuroinflammation plays a critical role in the pathological mechanisms in ischemic stroke. 25, 26 Here, we found that IMP, with good blood-brain barrier (BBB) permeability, 27 inhibited LPS-induced microglial activation and reduced the expression of pro-inflammatory cytokines, including iNOS, COX2, IL-1β, IL-6, and TNFα. Furthermore, IMP decreased the infarct volume and improved neurological deficits at 24 and 72 h after ischemic stroke and suppressed the microglial activation in vivo.

Mechanistically, IMP restrained the activation of MAPK and NF-κB signaling pathways in LPS-induced microglia, which might be an effective therapeutic strategy for relieving the ischemic brain injury. Notably, several chemicals with similar structures of IMP have also shown anti-inflammatory effects. For example, 8-MOP (8-methoxypsoralen) protects blood-brain barrier via the Nrf-2/ HO-1 pathway in experimental ischemic stroke. 28 Bergapten ameliorates peripheral neuropathy induced by vincristine via inhibition of NF-kappaB signaling and inflammatory cytokines. 29 Isoimperatorin suppressed airway inflammation in the model of asthma. 30 Therefore, further investigations into the structure analysis will be needed.

Microglia plays an important role in defending against pathogens, which maintains the homeostasis and inflammatory response. 31, 32 However, excessive and persistent inflammatory response mediated by over-activated microglia will release a large number of inflammatory mediators and neurotoxic substances. 33 Overloaded IL-1β, IL-6, and TNFα act on adjacent microglia to induce neuroinflammation and glia-activated feedback loops which aggravates the production of neurotoxic molecules. 34 In addition, excessive NO inhibits mitochondrial cytochrome oxidase, which results in neuronal apoptosis. 35 Minocycline treatment reduces infarct volume, hemorrhagic transformation, and blood-brain barrier permeability after MCAO by inhibiting microglial activation. 36 In addition, lncRNA-1810034E14Rik attenuates brain injury by reducing microglia activation in experimental ischemic stroke. 37 In the present study, our results showed IMP could suppress the microglial activation and reduce the expression of pro-inflammatory cytokines. Notably, only male mice were used in this study. Since sex differences are found in the pharmacokinetic profiles of imperatorin and its 2 metabolites, 38 The values were presented as the means ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001vs. DMSO group and microglial functions vary dynamically between sex differences after stroke, 39, 40 there might be sex differences in the protective effects of IMP against ischemic stroke, which will be explored in the following studies.

MAPK pathway is a major signal regulatory pathway sensitive to external stimuli. 41 After the activation of microglia, MAPK pathways can be activated to release a large number of pro-inflammatory cytokines and reactive oxygen species, leading to neuronal damage. 42 Semaglutide, a kind of diabetes drug, reduces infarct size and inflammation and normalizes neurogenesis by suppressing the phosphorylation of p38 and ERK of MAPK signaling pathways in a rat model of stroke. 43 Melatonin attenuates brain damage by inhibiting the JNK and p38 pathway. 44 JNK-IN-8, a c-Jun N-terminal kinase inhibitor, improves functional recovery through suppressing neuroinflammation in ischemic stroke. 45 In our study, these data demonstrated that IMP suppressed the phosphorylation of JNK, ERK, and p38 in LPStreated microglia.

As a key signal transduction factor in inflammatory response, NF-κB plays a central role in inflammatory cytokine-mediated inflammatory response. 46 The activation of NF-κB signaling aggravates the ischemic stroke injury, while inhibiting the phosphorylation of NF-κB could reduce the brain damage. 47, 48 Likewise, neural progenitor cell-derived extracellular vesicles reduces Evans blue extravasation and decreases ATP-binding cassette transporter B1 expression by F I G U R E 5 IMP suppressed the production of inflammatory cytokines and microglial activation in the brains of MCAO mice. (A) The mRNA levels of iNOS, IL-1β, IL-6, and TNFα in ischemic tissue were assessed by real-time PCR.

(B, C) The protein levels of iNOS, IL-1β, IL-6, and TNFα in ischemic tissue were assessed by Western blot. (D) Representative images of tissue sections from the ischemic penumbra collected 3 d after MCAO and stained with Iba1 and DAPI. Scale bar = 10 μm. n= 6 per group. **p < 0.01, ***p < 0.001, ****p < 0.0001 vs. sham group; #p < 0.05, ##p < 0.01 vs. DMSO group inhibiting the NF-κB pathway in stroke mice. 49 NF-κB and MAPK signaling pathways promote nucleotide-binding oligomerization domain (NOD)-like receptor (NLR) Pyrin domain containing 1 and 3 (NLRP1 and NLRP3) inflammasome activation in neurons following ischemic stroke. 50 JZL184 and deletion of monoacylglycerol lipase inhibit the activation of the MAPK and NF-κB pathways. 51 However, further research is needed to determine whether IMP plays an important role in ischemic stroke through the MAPK and NF-κB pathways.

In conclusion, our data uncovered that IMP exerted antiinflammatory effects in LPS-induced primary microglia and attenuated ischemic stroke injury and neurological deficits in experimental stroke, which might be associated with the inhibition of MAPK and NF-κB signaling pathways. These results suggested that IMP might provide an alternative treatment for ischemic stroke. Association for Science and Technology.

Authors declare that there are no conflicts of interest associated with this article.

The data that support the findings of this study are available from the corresponding author upon reasonable request.

https://orcid.org/0000-0001-5288-0319

Xiao-lei Zhu https://orcid.org/0000-0003-4696-9696

Heart disease and stroke statistics-2021 update: a report from the

Modulation of vascular integrity and neuroinflammation by peroxiredoxin 4 following cerebral ischemiareperfusion injury

Fluoxetine protects against IL-1beta-induced neuronal apoptosis via downregulation of p53

Dual functions of microglia in ischemic stroke

The anti-inflammatory effects of 4-((5-B romo-3-chloro-2-hydroxybenzyl) amino)-2-hydroxybenzoic acid in lipopolysaccharide-activated primary microglial cells

Specific depletion of resident microglia in the early stage of stroke reduces cerebral ischemic damage

Methane ameliorates spinal cord ischemia-reperfusion injury in rats: antioxidant, anti-inflammatory and anti-apoptotic activity mediated by Nrf2 activation

Microglia depletion exacerbates demyelination and impairs remyelination in a neurotropic coronavirus infection

Design, synthesis and preliminary evaluation of novel imperatorin derivatives as vasorelaxant agents

Imperatorin ameliorates mast cellmediated allergic airway inflammation by inhibiting MRGPRX2 and CamKII/ERK signaling pathway

Direct targeting of CREB1 with imperatorin inhibits TGFbeta2-ERK signaling to suppress esophageal cancer metastasis

Imperatorin interferes with LPS binding to the TLR4 co-receptor and activates the Nrf2 antioxidative pathway in RAW264.7 murine macrophage cells

Imperatorin ameliorates lipopolysaccharide induced memory deficit by mitigating proinflammatory cytokines, oxidative stress and modulating brain-derived neurotropic factor

Effects of imperatorin on apoptosis and synaptic plasticity in vascular dementia rats

Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer's disease model

The ARRIVE guidelines 2.0: updated guidelines for reporting animal research

Transforming growth factor betaactivated kinase 1-dependent microglial and macrophage responses aggravate long-term outcomes after ischemic stroke

LncRNA MALAT1 silencing protects against cerebral ischemia-reperfusion injury through miR-145 to regulate AQP4

Intracerebral transplantation of HLAhomozygous human iPSC-derived neural precursors ameliorates the behavioural and pathological deficits in a rodent model of ischaemic stroke

IL-4/STAT6 signaling facilitates innate hematoma resolution and neurological recovery after hemorrhagic stroke in mice

PSD-93 attenuates amyloid-beta-mediated cognitive dysfunction by promoting the catabolism of amyloidbeta

Tenascin-C preserves microglia surveillance and restricts leukocyte and more specifically, T cell infiltration of the ischemic brain

IL-2mAb reduces demyelination after focal cerebral ischemia by suppressing CD8(+) T cells

Boosting mTOR-dependent autophagy via upstream TLR4-MyD88-MAPK signalling and downstream NF-kappaB pathway quenches intestinal inflammation and oxidative stress injury

Ethyl pyruvate protects against bloodbrain barrier damage and improves long-term neurological outcomes in a rat model of traumatic brain injury

SIRP/CD47 signaling in neurological disorders

In vitro permeability analysis, pharmacokinetic and brain distribution study in mice of imperatorin, isoimperatorin and cnidilin in Radix Angelicae Dahuricae

Protective effects of 8-MOP on blood-brain barrier via the Nrf-2/HO-1 pathway in mice model of cerebral infarction

Bergapten ameliorates vincristine-induced peripheral neuropathy by inhibition of inflammatory cytokines and NFkappaB signaling

Isoimperatorin attenuates airway inflammation and mucus hypersecretion in an ovalbumin-induced murine model of asthma

STAT6/Arg1 promotes microglia/macrophage efferocytosis and inflammation resolution in stroke mice

Genome-wide transcriptomic analysis of microglia reveals impaired responses in aged mice after cerebral ischemia

Microglia-mediated inflammation and neurodegenerative disease

Inhibiting NLRP3 inflammasome activation prevents copper-induced neuropathology in a murine model of Wilson's disease

Knockdown of cathepsin D protects dopaminergic neurons against neuroinflammation-mediated neurotoxicity through inhibition of NF-kappaB signalling pathway in Parkinson's disease model

The biphasic function of microglia in ischemic stroke

LncRNA-1810034E14Rik reduces microglia activation in experimental ischemic stroke

Simultaneous determination of imperatorin and its 2 metabolites in dog plasma by using liquid chromatography-tandem mass spectrometry

Microglial/ Macrophage polarization and function in brain injury and repair after stroke

Potential microglia-based interventions for stroke

Sanweidoukou Decoction, a Chinese herbal formula, ameliorates beta-amyloid protein-induced neuronal insult via modulating MAPK/NF-kappaB signaling pathways: studies in vivo and in vitro

Critical roles of sphingosine kinase 1 in the regulation of neuroinflammation and neuronal injury after spinal cord injury

The diabetes drug semaglutide reduces infarct size, inflammation, and apoptosis, and normalizes neurogenesis in a rat model of stroke

A potent antioxidant endogenous neurohormone melatonin, rescued MCAO by attenuating oxidative stressassociated neuroinflammation

JNK-IN-8, a c-Jun N-terminal kinase inhibitor, improves functional recovery through suppressing neuroinflammation in ischemic stroke

Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK/p38 MAPK and NF-kappaB signaling

Inhibition of CD147 (cluster of differentiation 147) ameliorates acute ischemic stroke in mice by reducing thromboinflammation

Systematic understanding of the mechanism of baicalin against ischemic stroke through a network pharmacology approach

Neural progenitor cell-derived extracellular vesicles enhance blood-brain barrier integrity by NF-kappaB (nuclear factor-kappaB)-dependent regulation of ABCB1 (ATP-binding cassette transporter B1) in stroke mice

Evidence that NF-kappaB and MAPK signaling promotes NLRP inflammasome activation in neurons following ischemic stroke

Inhibiting monoacylglycerol lipase suppresses RANKL-induced osteoclastogenesis and alleviates ovariectomy-induced bone loss

Imperatorin inhibits mitogen-activated protein kinase and nuclear factor kappa-B signaling pathways and alleviates neuroinflammation in ischemic stroke